Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for VTE Prevention in Hemorrhagic Stroke
NCT01573169Phase 3Terminated
- Sponsor
- University of Perugia
- Start
- May 2012
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of Perugia. Started May 2012; status: terminated.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01573169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573169.